21-01-19 Integra LifeSciences Holdings Corporation completed the acquisition of ACell, Inc for approximately $410 million. CI
20-12-22 ACell, Inc. Announces CE Mark Approval CI
20-12-15 Integra LifeSciences Holdings Corporation entered into a definitive agreement to acquire ACell, Inc. for $400 million. CI
20-07-20 ACell, Inc. has withdrawn its IPO in the amount of $80 million. CI
20-06-26 ACell, Inc. has filed an IPO in the amount of $86.25 million. CI
19-09-05 ACell, Inc. Announces Launch of their New Product, Gentrix Hiatal at the 2019 Society of Laparoendoscopic Surgeons Minimally Invasive Surgery Week 2019 in New Orleans, Louisiana CI
19-09-04 ACell, Inc. and Southmedic Announce Canadian Launch of Gentrix Surgical Matrix Family of Products CI
19-04-08 ACell, Inc. Enters into Exclusive Long-Term Product Supply and Distribution Agreement with First Horizon, LLC and Weihai Jierui Medical Products Co., Ltd CI
18-10-15 ACell, Inc. and Southmedic Announce Canadian Launch of Cytal Wound Matrix and MicroMatrix CI
18-10-08 ACell's Gentrix Surgical Matrix Provides Exceptional Long-Term Results in Complex Patient Populations for Durable Reinforcement of Ventral Hernias CI
18-07-20 ACell to Host Grand Opening and Ribbon Cutting for Medical Learning Center CI
18-05-08 ACell, Inc. Names Nino Pionati as Vice President, International and Business Development CI
18-04-11 ACell, Inc. Announces Launch of Gentrix® Incisional CI
18-02-21 ACell, Inc. Announces New Distribution Agreement with Applied Tissue Technologies LLC CI
17-01-11 ACell, Inc. Announces Distribution Agreement with Southmedic, Incorporated CI
16-10-31 ACell, Inc. Appoints Sally Maher to Board of Directors CI
16-08-22 ACell, Inc. Names Brad Adams as Vice President of Sales CI
16-03-23 ACell, Inc. Receives FDA Clearance for Concurrent Use of its Wound Management Devices CI
16-01-11 ACell, Inc. Announces Management Changes CI
16-01-07 ACell, Inc. Introduces Cytal Wound Matrix for Complex, Full-Thickness Wounds CI
15-05-27 ACell, Inc. Announces Release of MatriStem Surgical Matrix Plus CI
15-03-15 ACell, Inc. Appoints David Elliot as Vice President, Marketing CI
15-01-04 ACell, Inc. Appoints Thomas Gilbert as a Chief Science Officer CI
14-12-15 ACell, Inc. Announces Management Changes CI
14-07-15 ACell, Inc. Announces First Patient in A U.S. Phase IV Clinical Trial CI
No results match your criteria
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!